Acadia Pharmaceuticals (ACAD) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | 29.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.64% |
| Dec 31, 2025 | -44.40% |
| Sep 30, 2025 | 66.29% |
| Jun 30, 2025 | 43.19% |
| Mar 31, 2025 | 6.33% |
| Dec 31, 2024 | 69.40% |
| Sep 30, 2024 | 58.00% |
| Jun 30, 2024 | 64.10% |
| Mar 31, 2024 | -29.62% |
| Dec 31, 2023 | 64.27% |
| Sep 30, 2023 | -36.59% |
| Jun 30, 2023 | -22.81% |
| Mar 31, 2023 | 41.96% |
| Dec 31, 2022 | -22.10% |
| Sep 30, 2022 | 63.61% |
| Jun 30, 2022 | -47.62% |
| Mar 31, 2022 | -32.70% |
| Dec 31, 2021 | -54.78% |
| Sep 30, 2021 | -79.08% |
| Jun 30, 2021 | -14.01% |
| Mar 31, 2021 | 75.94% |
| Dec 31, 2020 | 71.88% |
| Sep 30, 2020 | 17.35% |
| Jun 30, 2020 | 317.08% |
| Mar 31, 2020 | 77.39% |
| Dec 31, 2019 | 40.76% |
| Sep 30, 2019 | 503.27% |
| Jun 30, 2019 | 0.34% |
| Mar 31, 2019 | -16.14% |
| Dec 31, 2018 | 94.13% |
| Sep 30, 2018 | -43.26% |
| Jun 30, 2018 | -48.41% |
| Mar 31, 2018 | -26.09% |
| Dec 31, 2017 | -57.57% |
| Sep 30, 2017 | -26.72% |
| Jun 30, 2017 | 9.12% |
| Mar 31, 2017 | -10.18% |
| Dec 31, 2016 | 60.20% |
| Sep 30, 2016 | 117.06% |
| Jun 30, 2016 | 41.37% |
| Mar 31, 2016 | 129.27% |
| Dec 31, 2015 | 65.13% |
| Sep 30, 2015 | 94.67% |
| Jun 30, 2015 | 580.48% |
| Mar 31, 2015 | -20.77% |
| Dec 31, 2014 | 428.35% |
| Sep 30, 2014 | 208.13% |
| Jun 30, 2014 | -43.51% |
| Mar 31, 2014 | 423.19% |
| Dec 31, 2013 | -79.78% |
| Sep 30, 2013 | 47.24% |
| Jun 30, 2013 | 163.33% |
| Mar 31, 2013 | 231.70% |
| Dec 31, 2012 | 740.46% |
| Sep 30, 2012 | -3.62% |
| Jun 30, 2012 | 14.81% |
| Mar 31, 2012 | -18.61% |
| Dec 31, 2011 | 0.58% |
| Sep 30, 2011 | -13.87% |